Cogent Biosciences
Director, Corporate Accounts
Cogent Biosciences, Waltham, Massachusetts, United States, 02254
1 day ago Be among the first 25 applicants
Get AI-powered advice on this job and more exclusive features.
Who We Are Cogent Biosciences is a publicly traded biotechnology company dedicated to developing precision therapies for genetically defined diseases. By leveraging validated biology and a rational drug discovery approach, Cogent aims to create real solutions that address the underlying drivers of disease and offer meaningful hope to patients.
The company’s lead therapeutic candidate, bezuclastinib, is a highly selective tyrosine kinase inhibitor designed to potently target KIT D816V and other mutations in KIT exon 17. These mutations are known drivers of systemic mastocytosis (SM) and advanced gastrointestinal stromal tumors (GIST) – both serious conditions driven by oncogenic KIT signaling. Bezuclastinib is currently being evaluated in multiple registration-directed trials across Non-Advanced SM (NonAdvSM), Advanced SM (AdvSM), and GIST. In July 2025, Cogent announced that its registration-direct SUMMIT trial in patients with NonAdvSM achieved statistical significance across all primary and key secondary endpoints, and the company is on track to file its first New Drug Application for this patient population by the end of 2025. The company also remains on track to announce top‑line results for its APEX trial in patients with AdvSM in the second half of 2025 and for its PEAK trial in patients with GIST by the end of 2025. The company also has an ongoing Phase 1 study of its novel internally discovered FGFR2 inhibitor, and the Cogent Research Team is developing a portfolio of novel targeted therapies to help patients fighting other serious, genetically driven diseases targeting mutations in ErbB2, PI3Kα and KRAS.
Through its commitment to precision medicine and targeted innovation, Cogent Biosciences is working to transform the treatment landscape for patients with serious and underserved diseases. By leveraging validated biology and a rational drug discovery approach, Cogent aims to create real solutions that address the underlying drivers of disease. Our culture of inquisitiveness fuels continuous learning and innovation; we challenge assumptions, ask bold questions, and embrace a mindset of discovery to uncover transformative insights.
The Role The Corporate Account Director role will be responsible for building strategic relationships with Population‑Based Decision Makers (PBDMs) at the C and D Suite level across a list of key targeted oncology, allergy and GI accounts. The key responsibilities will be to gather customer insights/voice of customer, execute provider GPO contracts and management/pull‑through. In addition, the Account Directors will support access and on‑label integration into provider decision‑making platforms (ex. EMRs, formulary, and account‑level pathways, if applicable) along with medical affairs for Cogent Biosciences brands. The targeted accounts will include key academic, health systems, and community provider accounts. They will work closely with the other key functional areas within Cogent, including Sales, Medical, HEOR, Patient Support, Contracting, Commercial Ops & Marketing to develop appropriate support with their targeted accounts.
Responsibilities
Leverage account management and/or build strong partnerships with targeted accounts with C & D suite population‑based decision makers (PBDMs)
Sustain long‑term customer partnerships with assigned accounts, based on a deep understanding of the customer organization, structure, business strategy, and priorities.
Ability to build effective business plans that align with access goals to support brand and market access strategies
Strong knowledge of oncology or allergy provider landscape and prominent accounts
Effectively communicate value propositions for current product portfolio
Provider contract experience and contract management/pull‑through to support GPO contracts for Cogent brands
Conduct internal and external business reviews across aligned accounts with Cogent functions and Provider PBDM customers (Dir. Of Pharmacy, Medical Directors, Dir of Contracting etc.)
Effectively lead contract negotiation and execution, including pre‑contract financial ROI analysis, contract language negotiation, pull‑through development and execution, post contract measurement and analysis and formulary communication strategy.
Support access and on‑label integration into provider decision‑making platforms (ex. EMRs and account‑level pathways, if applicable) along with medical support.
Translate the voice of the PBDM customer into accountable and actionable insights to support Brand & MA strategies.
Support product access at the EMR, formulary and account‑level pathways, if applicable with Medical Support, (varies by account).
Work with cross‑functional partners including Sales, Medical, Marketing, HEOR, Patient Support and Contracting, as needed.
Develop and maintain an integrated business plan which illustrates account overviews, monitors contract progress and performance, and account penetration at the enterprise and local level.
Provide in‑depth analysis related to accounts, market trends, competitive activity, contract performance, and personnel.
Communicate regularly to senior management for the opportunities, challenges, and performance of accounts.
Ensure strategies and KPIs are implemented and monitored to achieve our commercial goals while working within the assigned budget.
Works within Cogent’s compliance policies.
Qualifications Basic Qualifications
Requires bachelor’s degree, MBA
Minimum of 10 years of pharmaceutical experience. Preferred candidates with a minimum of 5 years of oncology and/or rare disease account management experience.
Knowledge & understanding of oncology or allergy landscape and customer accounts
Pharmacy benefit experience and In‑office dispensing/specialty pharmacy knowledge
Ability to travel overnight up to 50% (travel consists of working with field sales, attending business meetings, industry meetings, and working with key customers). Preferred candidates will have established key provider PBDM contacts at the targeted accounts.
Preferred Qualifications
Strong communication, account management & presentation skills
Strong business and analytical acumen
Oral oncology experience for a launch product is required. Launch experience on behalf of a publicly traded company’s first market entry preferred.
Proven ability to identify issues and provide effective solutions to address them. Ability to effectively communicate the solution and its value to affected parties.
Well established relationships with key customers including regional & national payers and State Medicaid programs.
Excellent interpersonal skills and cross‑functional team success.
Possess a good foundational understanding of current issues within the marketplace, pharmaceutical industry, and national health care system.
Ability to evaluate risk/benefit/return on investment‑based decisions and discern trends occurring within the market.
Ability to work in a cross‑functional environment and handle multiple tasks.
Specialty Product experience
Start‑up & oncology launch experience.
Salary Range 220,000 - 260,000 $USD
Target Bonus: 20%
Exact compensation will vary based on skills, experience, and location.
Our Locations Waltham, MA: Our Boston office includes an open office layout that has recently undergone a makeover designed for collaboration and giving our employees the best work place possible. Free access is provided for both on‑site parking and gym facilities in the building.
Boulder, CO: We have just moved into our new state‑of‑the‑art Research Facility in the fast‑growing biopharmaceutical hub in the greater Denver/Boulder corridor. Our CEO is based full‑time in this location and we are proud to call this the home of Cogent’s discovery research organization.
Our Offer To You To attract the very best talent, we offer a generous benefits package that includes competitive pay, performance‑based bonus, stock options, insurance coverage (health, dental, life, and disability), competitive time‑off, a 401(k) plan, and commuter/parking benefits.
We are proud to be an Equal Opportunity Employer. Our goal is to have a diverse workforce. We do not discriminate on the basis of race, age, color, religion, national origin, gender, sexual orientation, gender identity or expression, veteran status or disability, or any other status protected under federal, state, or local law. All employment is decided on the basis of qualifications, merit, and business need.
#J-18808-Ljbffr
Get AI-powered advice on this job and more exclusive features.
Who We Are Cogent Biosciences is a publicly traded biotechnology company dedicated to developing precision therapies for genetically defined diseases. By leveraging validated biology and a rational drug discovery approach, Cogent aims to create real solutions that address the underlying drivers of disease and offer meaningful hope to patients.
The company’s lead therapeutic candidate, bezuclastinib, is a highly selective tyrosine kinase inhibitor designed to potently target KIT D816V and other mutations in KIT exon 17. These mutations are known drivers of systemic mastocytosis (SM) and advanced gastrointestinal stromal tumors (GIST) – both serious conditions driven by oncogenic KIT signaling. Bezuclastinib is currently being evaluated in multiple registration-directed trials across Non-Advanced SM (NonAdvSM), Advanced SM (AdvSM), and GIST. In July 2025, Cogent announced that its registration-direct SUMMIT trial in patients with NonAdvSM achieved statistical significance across all primary and key secondary endpoints, and the company is on track to file its first New Drug Application for this patient population by the end of 2025. The company also remains on track to announce top‑line results for its APEX trial in patients with AdvSM in the second half of 2025 and for its PEAK trial in patients with GIST by the end of 2025. The company also has an ongoing Phase 1 study of its novel internally discovered FGFR2 inhibitor, and the Cogent Research Team is developing a portfolio of novel targeted therapies to help patients fighting other serious, genetically driven diseases targeting mutations in ErbB2, PI3Kα and KRAS.
Through its commitment to precision medicine and targeted innovation, Cogent Biosciences is working to transform the treatment landscape for patients with serious and underserved diseases. By leveraging validated biology and a rational drug discovery approach, Cogent aims to create real solutions that address the underlying drivers of disease. Our culture of inquisitiveness fuels continuous learning and innovation; we challenge assumptions, ask bold questions, and embrace a mindset of discovery to uncover transformative insights.
The Role The Corporate Account Director role will be responsible for building strategic relationships with Population‑Based Decision Makers (PBDMs) at the C and D Suite level across a list of key targeted oncology, allergy and GI accounts. The key responsibilities will be to gather customer insights/voice of customer, execute provider GPO contracts and management/pull‑through. In addition, the Account Directors will support access and on‑label integration into provider decision‑making platforms (ex. EMRs, formulary, and account‑level pathways, if applicable) along with medical affairs for Cogent Biosciences brands. The targeted accounts will include key academic, health systems, and community provider accounts. They will work closely with the other key functional areas within Cogent, including Sales, Medical, HEOR, Patient Support, Contracting, Commercial Ops & Marketing to develop appropriate support with their targeted accounts.
Responsibilities
Leverage account management and/or build strong partnerships with targeted accounts with C & D suite population‑based decision makers (PBDMs)
Sustain long‑term customer partnerships with assigned accounts, based on a deep understanding of the customer organization, structure, business strategy, and priorities.
Ability to build effective business plans that align with access goals to support brand and market access strategies
Strong knowledge of oncology or allergy provider landscape and prominent accounts
Effectively communicate value propositions for current product portfolio
Provider contract experience and contract management/pull‑through to support GPO contracts for Cogent brands
Conduct internal and external business reviews across aligned accounts with Cogent functions and Provider PBDM customers (Dir. Of Pharmacy, Medical Directors, Dir of Contracting etc.)
Effectively lead contract negotiation and execution, including pre‑contract financial ROI analysis, contract language negotiation, pull‑through development and execution, post contract measurement and analysis and formulary communication strategy.
Support access and on‑label integration into provider decision‑making platforms (ex. EMRs and account‑level pathways, if applicable) along with medical support.
Translate the voice of the PBDM customer into accountable and actionable insights to support Brand & MA strategies.
Support product access at the EMR, formulary and account‑level pathways, if applicable with Medical Support, (varies by account).
Work with cross‑functional partners including Sales, Medical, Marketing, HEOR, Patient Support and Contracting, as needed.
Develop and maintain an integrated business plan which illustrates account overviews, monitors contract progress and performance, and account penetration at the enterprise and local level.
Provide in‑depth analysis related to accounts, market trends, competitive activity, contract performance, and personnel.
Communicate regularly to senior management for the opportunities, challenges, and performance of accounts.
Ensure strategies and KPIs are implemented and monitored to achieve our commercial goals while working within the assigned budget.
Works within Cogent’s compliance policies.
Qualifications Basic Qualifications
Requires bachelor’s degree, MBA
Minimum of 10 years of pharmaceutical experience. Preferred candidates with a minimum of 5 years of oncology and/or rare disease account management experience.
Knowledge & understanding of oncology or allergy landscape and customer accounts
Pharmacy benefit experience and In‑office dispensing/specialty pharmacy knowledge
Ability to travel overnight up to 50% (travel consists of working with field sales, attending business meetings, industry meetings, and working with key customers). Preferred candidates will have established key provider PBDM contacts at the targeted accounts.
Preferred Qualifications
Strong communication, account management & presentation skills
Strong business and analytical acumen
Oral oncology experience for a launch product is required. Launch experience on behalf of a publicly traded company’s first market entry preferred.
Proven ability to identify issues and provide effective solutions to address them. Ability to effectively communicate the solution and its value to affected parties.
Well established relationships with key customers including regional & national payers and State Medicaid programs.
Excellent interpersonal skills and cross‑functional team success.
Possess a good foundational understanding of current issues within the marketplace, pharmaceutical industry, and national health care system.
Ability to evaluate risk/benefit/return on investment‑based decisions and discern trends occurring within the market.
Ability to work in a cross‑functional environment and handle multiple tasks.
Specialty Product experience
Start‑up & oncology launch experience.
Salary Range 220,000 - 260,000 $USD
Target Bonus: 20%
Exact compensation will vary based on skills, experience, and location.
Our Locations Waltham, MA: Our Boston office includes an open office layout that has recently undergone a makeover designed for collaboration and giving our employees the best work place possible. Free access is provided for both on‑site parking and gym facilities in the building.
Boulder, CO: We have just moved into our new state‑of‑the‑art Research Facility in the fast‑growing biopharmaceutical hub in the greater Denver/Boulder corridor. Our CEO is based full‑time in this location and we are proud to call this the home of Cogent’s discovery research organization.
Our Offer To You To attract the very best talent, we offer a generous benefits package that includes competitive pay, performance‑based bonus, stock options, insurance coverage (health, dental, life, and disability), competitive time‑off, a 401(k) plan, and commuter/parking benefits.
We are proud to be an Equal Opportunity Employer. Our goal is to have a diverse workforce. We do not discriminate on the basis of race, age, color, religion, national origin, gender, sexual orientation, gender identity or expression, veteran status or disability, or any other status protected under federal, state, or local law. All employment is decided on the basis of qualifications, merit, and business need.
#J-18808-Ljbffr